Acessibilidade / Reportar erro

Hereditary hemorrhagic telangiectasia: a new surgycal approach

epistaxis; rendu-osler-weber; telangiectasia

CASE REPORT

Hereditary hemorrhagic telangiectasia- a new surgycal approach

Diego Rosado de MirandaI; Márcio Meira LimaII; André Luiz Monteiro CavalcanteIII; Elias Bezerra LeiteIV; Sebastião Diógenes PinheiroV; Marcos Rabelo de FreitasVI

IGraduated from the UFRN - 2000. ENT Resident-UFC

IIMD. Graduated from UFC. ENT Resident -UFC

IIIENT - UFC, Otorhinolaryngologist – Department of otorhinolaryngology – Federal University of Ceará (UFC)

IVENT - UFC. Otorhinolaryngologist – Department of otorhinolaryngology – Federal University of Ceará

VPhD in Medicine – University of São Paulo. Adjunct Professor of Otorhinolaryngologist – UFC Medical School.

VIM.S. in Medicine - USP/ Ribeirão Preto. Assistant Professor of Otorhinolaryngology UFC

Mailing Address Mailing Address: R. Prof. Costa Mendes 1608 Rodolfo Teófilo 60430-140 Dep. de Cirurgia da Faculdade de Medicina da Universidade Federal do Ceará 3º andar.

Keywords: epistaxis, rendu-osler-weber, telangiectasia.

INTRODUCTION

Hereditary Hemorrhagic telangiectasia (HHT), or Rendu-Osler-Weber disease, is a vascular anomaly characterized by multiple dilations of skin and mucosa capillaries and venules. It is an autosomal dominant disease, equally distributed between both genders and its incidence is of 1-2/100.000 inhabitants.1

Bleeding may occur in numerous places; however, epistaxis is the most common, present in 90% of the cases2. The basic lesion is found on the vessels’ walls, with defects in the elastic and muscular layers that make them more prone to bleeding1,3.

Many treatment modalities have been used to control epistaxis; none of them have rendered entirely satisfactory result4. Options are nasal packing, hormone-therapy, vascular embolizations, fascioplasty and septodermoplasty. Young’s surgery is based on nasal occlusion, thus preventing the friction between air and the telangiectasia, precluding epistaxis episodes.6

CASE REPORT

A.B.L., 56 years old, history of recurrent epistaxis, mainly affecting the left side, since he was 15 years of age. He had been submitted to many blood transfusions, as well as cauterizations and fascioplasty, with less than satisfactory results. At hospital admittance he had lost much weight and had excessively pale skin (+++/4+). Multiple telangiectasia lesions were seen on the upper lip, nasal tip and nasal cavities. His hematocrit count was 24%. The patient was then submitted to Young’s procedure on the left side, since this one was the most symptomatic one. A circular incision was carried out on the skin-mucous joint (Figure 1), preserving the vibrissae on the side of the nostril, and suturing up in two planes, a more internal mucous layer and another external, skin layer. After two years and three months of follow up there was no other epistaxis episode and he also had hematologic normalization. There was no respiratory disorder and the cosmetic aspect was very satisfactory.


DISCUSSION

Repetition epistaxis is the most common HHT symptom, present in 90% of the cases2. This was the only symptom our patient had. The condition started on his second decade of life, becoming increasingly more intense, in agreement with data from the literature.

The effectiveness of Young’s technique in controlling epistaxis in patients with HHT is due to terminating with the air turbulence in a frail mucosa bearing diseased vassels6. This procedure is not much reported in the literature, and it is extremely efficient in controlling recurrent epistaxis. Our patient did not have any epistaxis episode after two years and four months of surgery, and such time is in agreement with data presented in the literature.

FINAL REMARKS

Young’s procedure proved to be efficient in controlling recurrent epistaxis secondary to HHT. We did not observe any respiratory alteration, and nasal occlusion was well tolerated. Although the number of patients submitted to this technique is still small, we may state that these procedures may be included in the therapeutic weaponry of our specialty in an attempt to minimize the symptoms of these patients, and thus improve their life quality.

REFERENCES

Paper submitted to the RBORL - SGP (Publications Management System – Brazilian Journal of Otorhinolaryngology) on April 27, 2005, and approved on May 1st, 2006. cod. 273.

Universidade Federal do Ceará - Faculdade de Medicina - Hospital Universitário Walter Cantídio, Serviço de Otorrinolaringologia.

  • 1
    Pau H, Carney AS, Murty GE. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): otorhinolaryngological manifestations. Clin Otolaringol 2001;26:93-8.
  • 2
    Byahatti SV, Rebeiz EE, Shapshay SM. Hereditary Haemorrhagia Telangiectasia: What the otolaryngologist should know. Am J Rhinol 1997;11:55-62.
  • 3
    Gluckman JL, Portugal LG. Modified Youngs procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia. Laringoscope 1994;104:1174-7.
  • 4
    Jahnke V. Ultrastructure of Hereditary Hemorrhagic Telangiectasia. Arch Otololaryngol 1970;91:262-5.
  • 5
    Hashimoto K and Pritzker MS. Hereditary hemorrhagic telangiectasia.: An Eletron microscopic study. Oral surg 1972;34:751-7.
  • 6
    Young A. Closure of the Nostrils in Atrophic Rhinitis. J Laryngol Otol 1997, 81:515-524.
  • Mailing Address:

    R. Prof. Costa Mendes 1608
    Rodolfo Teófilo 60430-140
    Dep. de Cirurgia da Faculdade de Medicina da Universidade Federal do Ceará 3º andar.
  • Publication Dates

    • Publication in this collection
      16 May 2007
    • Date of issue
      Feb 2007

    History

    • Accepted
      01 May 2006
    • Received
      27 Apr 2005
    ABORL-CCF Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial Av. Indianápolis, 740, 04062-001 São Paulo SP - Brazil, Tel./Fax: (55 11) 5052-9515 - São Paulo - SP - Brazil
    E-mail: revista@aborlccf.org.br